Good prognosis of adult hemophagocytic lymphohistiocytosis associated with the germline HAVCR2 mutation

Exp Hematol. 2023 Sep-Oct:125-126:20-24.e4. doi: 10.1016/j.exphem.2023.07.005. Epub 2023 Jul 19.

Abstract

Hemophagocytic lymphohistiocytosis (HLH) in adults may be idiopathic or secondary to various conditions. Recent studies identified germline hepatitis A virus-cellular receptor 2 (HAVCR2) mutations in subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with HLH. The roles of this mutation in HLH, especially in idiopathic group, have never been explored. Of the 65 HLH cases, we detected germline HAVCR2Y82C mutations in nine (13.8%) cases (five SPTCL and four idiopathic HLH). Other causes of HLH were hematologic malignancies excluding SPTCL (32.3%), idiopathic HLH without HAVCR2 mutation (29.2%), infections (15.3%), and autoimmune diseases (9.2%). Germline HAVCR2 mutation was significantly associated with less anemia and better survival. This defines a distinct subgroup of HLH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Germ Cells
  • Hepatitis A Virus Cellular Receptor 2 / genetics
  • Humans
  • Lymphohistiocytosis, Hemophagocytic* / genetics
  • Mutation
  • Prognosis

Substances

  • HAVCR2 protein, human
  • Hepatitis A Virus Cellular Receptor 2

Supplementary concepts

  • Subcutaneous panniculitis-like T-cell lymphoma